Nelson, W G <br/><br/>
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  2000 
 - S67-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/pl00014053  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Neoplasm--blood<br/>Cancer Vaccines--genetics<br/>Carcinoma, Renal Cell--immunology<br/>Dose-Response Relationship, Immunologic<br/>Female<br/>Gene Transfer Techniques<br/>Genetic Engineering<br/>Granulocyte-Macrophage Colony-Stimulating Factor--genetics<br/>Humans<br/>Hypersensitivity, Delayed--immunology<br/>Kidney Neoplasms--immunology<br/>Male<br/>Middle Aged<br/>Prostatic Neoplasms--immunology<br/>Retroviridae--genetics